AP Biosciences (ROCO:6945) General and Admin. Expense: NT$100.69 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6945 AP Biosciences Inc ROCO:6945
21 GF Score
Price NT$101.50
! 1 Warning Sign
View Full Analysis

What is AP Biosciences General and Admin. Expense?

AP Biosciences ROCO:6945 +1.50% 21 General and Admin. Expense is NT$100.69 Mil as of Jun. 2026. GuruFocus rates ROCO:6945 with a GF Score™ of 21/100. The stock has 1 warning sign investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. AP Biosciences's General and Admin. Expense for the three months ended in Jun. 2026 was NT$30.86 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 was NT$100.69 Mil.

AP Biosciences General and Admin. Expense Related Terms

AP Biosciences General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for AP Biosciences's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AP Biosciences General and Admin. Expense Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial 19.90 34.82 43.13 73.11 86.61

AP Biosciences Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.11 21.61 23.88 24.35 30.86
ROCO:6945
21GF Score
AP Biosciences Inc ROCO:6945
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AP Biosciences General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$100.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of NT$100.69 Mil mean?
AP Biosciences (ROCO:6945) has a General and Admin. Expense of NT$100.69 Mil as of Jun. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on AP Biosciences and its competitors.
Is AP Biosciences' General and Admin. Expense too high?
AP Biosciences' current General and Admin. Expense is NT$100.69 Mil. Overall, AP Biosciences has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does AP Biosciences' General and Admin. Expense compare to VRTX and REGN?
AP Biosciences' General and Admin. Expense of NT$100.69 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on AP Biosciences and its competitors. AP Biosciences's current General and Admin. Expense is NT$100.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AP Biosciences stock overvalued right now?
AP Biosciences (ROCO:6945) has a current General and Admin. Expense of NT$100.69 Mil. The current General and Admin. Expense is NT$100.69 Mil. AP Biosciences' overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For AP Biosciences (ROCO:6945), the current General and Admin. Expense is NT$100.69 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AP Biosciences Business Description

Address No. 3, Park Street, 17th Floor, Taipei, TWN
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.
21GF Score

Get the complete analysis for ROCO:6945

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$101.50
Price